Alok Kripal Tewari, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms, Germ Cell and Embryonal | 3 | 2023 | 484 | 0.840 |
Why?
|
Androgen Antagonists | 3 | 2021 | 1350 | 0.690 |
Why?
|
Prostatic Neoplasms | 8 | 2022 | 11039 | 0.550 |
Why?
|
Orchiectomy | 3 | 2023 | 466 | 0.500 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1780 | 0.460 |
Why?
|
Metribolone | 1 | 2012 | 13 | 0.450 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2013 | 414 | 0.440 |
Why?
|
Receptors, Androgen | 4 | 2021 | 1057 | 0.430 |
Why?
|
Sp1 Transcription Factor | 1 | 2012 | 144 | 0.410 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2458 | 0.400 |
Why?
|
Repressor Proteins | 1 | 2021 | 3020 | 0.360 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2021 | 1509 | 0.360 |
Why?
|
Chromatin | 4 | 2022 | 2917 | 0.320 |
Why?
|
Nuclear Proteins | 3 | 2021 | 5851 | 0.310 |
Why?
|
Testicular Neoplasms | 2 | 2023 | 761 | 0.300 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7721 | 0.270 |
Why?
|
Genomics | 2 | 2021 | 5692 | 0.260 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5163 | 0.250 |
Why?
|
Seminoma | 1 | 2023 | 136 | 0.210 |
Why?
|
Receptors, Transforming Growth Factor beta | 2 | 2013 | 314 | 0.210 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2021 | 11472 | 0.200 |
Why?
|
Tumor Microenvironment | 4 | 2021 | 3564 | 0.200 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2024 | 241 | 0.200 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 185 | 0.190 |
Why?
|
Proteoglycans | 2 | 2013 | 834 | 0.180 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2021 | 315 | 0.170 |
Why?
|
Transcription Factors | 5 | 2022 | 12164 | 0.170 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 526 | 0.160 |
Why?
|
Immunologic Factors | 2 | 2021 | 1575 | 0.160 |
Why?
|
Quality Control | 1 | 2021 | 841 | 0.160 |
Why?
|
Gene Library | 1 | 2021 | 1076 | 0.160 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 325 | 0.150 |
Why?
|
Prostatectomy | 2 | 2021 | 1871 | 0.150 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 730 | 0.140 |
Why?
|
Gene Dosage | 1 | 2021 | 1251 | 0.140 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4801 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1052 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2021 | 8425 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3585 | 0.120 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 1786 | 0.120 |
Why?
|
Immunotherapy | 3 | 2021 | 4414 | 0.120 |
Why?
|
Databases, Genetic | 1 | 2021 | 1780 | 0.120 |
Why?
|
Epothilones | 1 | 2013 | 44 | 0.110 |
Why?
|
Tubulin Modulators | 1 | 2013 | 110 | 0.110 |
Why?
|
Stilbenes | 1 | 2012 | 156 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 216 | 0.100 |
Why?
|
Deoxyribonuclease I | 1 | 2012 | 228 | 0.100 |
Why?
|
Binding Sites | 3 | 2022 | 6115 | 0.100 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2013 | 599 | 0.100 |
Why?
|
Pyrimidines | 2 | 2021 | 2933 | 0.100 |
Why?
|
Tumor Escape | 1 | 2013 | 349 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2721 | 0.090 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2013 | 520 | 0.090 |
Why?
|
Melanoma, Experimental | 1 | 2013 | 559 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9410 | 0.090 |
Why?
|
Primates | 1 | 2012 | 543 | 0.090 |
Why?
|
Risk | 1 | 2021 | 9679 | 0.080 |
Why?
|
Cell Line, Tumor | 6 | 2021 | 16665 | 0.080 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2012 | 794 | 0.080 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13655 | 0.080 |
Why?
|
Drug Design | 1 | 2013 | 1078 | 0.080 |
Why?
|
Microtubules | 1 | 2013 | 1090 | 0.070 |
Why?
|
Genome, Human | 3 | 2022 | 4420 | 0.070 |
Why?
|
Male | 14 | 2024 | 349538 | 0.070 |
Why?
|
Cerebellar Neoplasms | 1 | 2012 | 585 | 0.070 |
Why?
|
Humans | 24 | 2024 | 742088 | 0.070 |
Why?
|
Medulloblastoma | 1 | 2012 | 681 | 0.070 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2009 | 257 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2012 | 987 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3123 | 0.070 |
Why?
|
Neuroblastoma | 1 | 2013 | 1225 | 0.070 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2005 | 248 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1659 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4229 | 0.060 |
Why?
|
Dietary Carbohydrates | 1 | 2009 | 904 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6754 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2012 | 1937 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3557 | 0.060 |
Why?
|
Retroperitoneal Space | 1 | 2023 | 172 | 0.060 |
Why?
|
Quality Improvement | 1 | 2018 | 3738 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 8829 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7901 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 256 | 0.050 |
Why?
|
Dietary Fats | 1 | 2009 | 2017 | 0.050 |
Why?
|
Robotics | 1 | 2008 | 892 | 0.050 |
Why?
|
Insulin | 2 | 2012 | 6575 | 0.050 |
Why?
|
Neoplasms | 2 | 2021 | 21596 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5304 | 0.040 |
Why?
|
Signal Transduction | 4 | 2021 | 23387 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17400 | 0.040 |
Why?
|
Protein Binding | 3 | 2022 | 9387 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3639 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 628 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1248 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1791 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 628 | 0.040 |
Why?
|
Laparoscopy | 1 | 2008 | 2121 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 861 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 713 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 537 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2008 | 3391 | 0.030 |
Why?
|
Mice, SCID | 2 | 2012 | 2715 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2005 | 1884 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1727 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1119 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1366 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9325 | 0.030 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2013 | 47 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2303 | 0.030 |
Why?
|
Chemokine CCL22 | 1 | 2013 | 26 | 0.030 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 109 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 250 | 0.030 |
Why?
|
Animals | 6 | 2013 | 168561 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 12071 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6347 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2013 | 768 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2723 | 0.020 |
Why?
|
Gene Expression | 2 | 2013 | 7790 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 3913 | 0.020 |
Why?
|
Genes, p53 | 1 | 2012 | 755 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2085 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2013 | 749 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 123 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6756 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11001 | 0.020 |
Why?
|
Morpholines | 1 | 2012 | 561 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2009 | 3920 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4595 | 0.020 |
Why?
|
Aminopyridines | 1 | 2012 | 541 | 0.020 |
Why?
|
Ketones | 1 | 2009 | 189 | 0.020 |
Why?
|
Species Specificity | 1 | 2012 | 2479 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4438 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2012 | 914 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 423 | 0.020 |
Why?
|
Quinolines | 1 | 2012 | 719 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 62966 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1525 | 0.020 |
Why?
|
Medication Adherence | 1 | 2018 | 2055 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2009 | 551 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 3001 | 0.020 |
Why?
|
Ribonuclease H | 1 | 2005 | 45 | 0.020 |
Why?
|
Imidazoles | 1 | 2012 | 1205 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2013 | 2006 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3862 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9185 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2023 | 77098 | 0.020 |
Why?
|
Mice | 4 | 2013 | 81045 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2012 | 847 | 0.020 |
Why?
|
Cerebellum | 1 | 2012 | 1490 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2425 | 0.020 |
Why?
|
HIV Reverse Transcriptase | 1 | 2005 | 213 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2005 | 683 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6382 | 0.020 |
Why?
|
Retroelements | 1 | 2005 | 164 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9639 | 0.010 |
Why?
|
Fatty Liver | 1 | 2009 | 728 | 0.010 |
Why?
|
Models, Chemical | 1 | 2005 | 626 | 0.010 |
Why?
|
Alanine | 1 | 2005 | 572 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2005 | 699 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2107 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4369 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2013 | 2723 | 0.010 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2005 | 484 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 5979 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1723 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2940 | 0.010 |
Why?
|
Thiazoles | 1 | 2009 | 1484 | 0.010 |
Why?
|
Androgens | 1 | 2009 | 1271 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15244 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 2014 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9735 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2892 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2502 | 0.010 |
Why?
|
Point Mutation | 1 | 2005 | 1624 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10248 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 13029 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12344 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3847 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15994 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53187 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
Viral Proteins | 1 | 2005 | 1899 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11470 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10472 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2009 | 3861 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 21821 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16331 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6249 | 0.010 |
Why?
|
Mutation | 2 | 2012 | 29717 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2005 | 2749 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13814 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18006 | 0.010 |
Why?
|
Apoptosis | 1 | 2009 | 9715 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5522 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13256 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 18112 | 0.010 |
Why?
|
Female | 3 | 2021 | 379592 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7289 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 19223 | 0.010 |
Why?
|
HIV-1 | 1 | 2005 | 6934 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39004 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40054 | 0.000 |
Why?
|
Middle Aged | 2 | 2008 | 213127 | 0.000 |
Why?
|
Aged | 1 | 2008 | 162944 | 0.000 |
Why?
|